Matthew J. Zimpfer - Feb 19, 2025 Form 4/A - Amendment Insider Report for CNO Financial Group, Inc. (CNO)

Role
General Counsel
Signature
Heidi M. Krings, Attorney-in-Fact
Stock symbol
CNO
Transactions as of
Feb 19, 2025
Transactions value $
-$1,910,974
Form type
4/A - Amendment
Date filed
2/24/2025, 05:48 PM
Date Of Original Report
Feb 21, 2025
Previous filing
Feb 13, 2025
Next filing
Mar 27, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNO Common Stock Options Exercise $709K +40.8K +14.28% $17.38 327K Feb 19, 2025 Direct
transaction CNO Common Stock Sale -$1.69M -40.8K -12.49% $41.49 286K Feb 19, 2025 Direct F1, F2
transaction CNO Common Stock Options Exercise $709K +40.8K +14.28% $17.38 327K Feb 21, 2025 Direct
transaction CNO Common Stock Sale -$1.64M -40.8K -12.49% $40.11 286K Feb 21, 2025 Direct F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNO Employee Stock Option (Right to Buy) Options Exercise $0 -40.8K -50% $0.00 40.8K Feb 19, 2025 Common Stock 81.6K $17.38 Direct F5
transaction CNO Employee Stock Option (Right to Buy) Options Exercise $0 -40.8K -100% $0.00 0 Feb 21, 2025 Common Stock 40.8K $17.38 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan adopted on August 23, 2024.
F2 Reflects the weighted average sale price. Shares were sold at prices ranging from $41.20 per share to $41.80 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
F3 Reflects the weighted average sale price. Shares were sold at prices ranging from $39.66 per share to $41.00 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
F4 This amendment corrects (i) the presentation of the exercise of stock options and (ii) the amount of securities beneficially owned following the transactions.
F5 One-half of the stock options vested on February 23, 2018, and one-half vested on February 23, 2019.